IGF1 and acute lymphoblastic leukemia: Our observation that IGF-1 rescued the inhibition of pre-B ALL cells by GZD824 treatment led us to hypothesize that GZD824 would directly restrict IRS1 expression, which would result in a subsequent activation of AKT in pre-B ALL cells.